Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001919246-26-000055
Filing Date
2026-04-06
Accepted
2026-04-06 17:03:21
Documents
1
Period of Report
2026-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1775509399.html 4  
1 FORM 4 wk-form4_1775509399.xml 4 6680
  Complete submission text file 0001919246-26-000055.txt   8348
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address
Malamut Richard (Reporting) CIK: 0001772168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41964 | Film No.: 26842012

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)